TY - JOUR
T1 - Brief, Non-Pharmacological, Interventions for Pediatric Anxiety
T2 - Meta-Analysis and Evidence Base Status
AU - Stoll, Ryan D.
AU - Pina, Armando A.
AU - Schleider, Jessica
N1 - Funding Information:
This work was supported in part by a prevention and implementation science fellowship awarded to R. Stoll, T32 DA039772 01 from the National Institute on Drug Abuse and grant number K01MH086687 awarded to A. Pina from the National Institute of Mental Health. The content is solely the responsibility of the authors and does not represent the official views of the funding agencies. We gratefully acknowledge Drs. Nancy Gonzales, David MacKinnon, and Marisol Perez for their feedback on this article.
Publisher Copyright:
© 2020, © 2020 Society of Clinical Child & Adolescent Psychology.
PY - 2020/7/3
Y1 - 2020/7/3
N2 - In 1998, Ost published [One-session treatment of specific phobias–a rapid and effective method] [in Swedish] giving rise to the idea that brief, intensive, and concentrated psychosocial interventions could exhibit public health impact. At this juncture, and per criteria of the Society for Clinical Child and Adolescent Psychology, there are data supporting that brief, non-pharmacological intervention [prescriptions] for pediatric anxiety can be considered well-established or probably efficacious. In addition, data from 76 randomized controlled trials (N = 17,203 youth) yield an overall mean effect size of 0.19 on pediatric anxiety outcomes (pre-post). Note, however, that effect sizes vary significantly. These data point to the capacity for clinical change coming from in-vivo exposures for specific phobias (~3 h, one session), CBT with social skills training (~3 h, six sessions for indicated prevention and early intervention), and CBT-based parent training (~6 h, eight digital modules with clinician support). Given such evidence, we recommend efforts be made to establish ways to position such treatment innovations for rapid deployment facilitated by high-quality training, monitoring, technical assistance, and ongoing disclosures.
AB - In 1998, Ost published [One-session treatment of specific phobias–a rapid and effective method] [in Swedish] giving rise to the idea that brief, intensive, and concentrated psychosocial interventions could exhibit public health impact. At this juncture, and per criteria of the Society for Clinical Child and Adolescent Psychology, there are data supporting that brief, non-pharmacological intervention [prescriptions] for pediatric anxiety can be considered well-established or probably efficacious. In addition, data from 76 randomized controlled trials (N = 17,203 youth) yield an overall mean effect size of 0.19 on pediatric anxiety outcomes (pre-post). Note, however, that effect sizes vary significantly. These data point to the capacity for clinical change coming from in-vivo exposures for specific phobias (~3 h, one session), CBT with social skills training (~3 h, six sessions for indicated prevention and early intervention), and CBT-based parent training (~6 h, eight digital modules with clinician support). Given such evidence, we recommend efforts be made to establish ways to position such treatment innovations for rapid deployment facilitated by high-quality training, monitoring, technical assistance, and ongoing disclosures.
UR - http://www.scopus.com/inward/record.url?scp=85083548131&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083548131&partnerID=8YFLogxK
U2 - 10.1080/15374416.2020.1738237
DO - 10.1080/15374416.2020.1738237
M3 - Article
C2 - 32285692
AN - SCOPUS:85083548131
SN - 1537-4416
VL - 49
SP - 435
EP - 459
JO - Journal of clinical child psychology
JF - Journal of clinical child psychology
IS - 4
ER -